Japanese companies are reaffirming their long-term commitment to the Chinese market, viewing its scale, growth prospects, and innovation potential as outweighing bilateral tensions. For overseas medical aesthetics buyers and distributors, this signals sustained supply-chain stability and continued access to Japan's advanced manufacturing, R&D, and talent base in China, which are critical for sourcing high-quality aesthetic devices, injectables, and OEM services.
Market signal
According to a white paper from the Japanese Chamber of Commerce and Industry in China, about 85% of Japanese-funded businesses in China plan to stay committed to the market. China hosts roughly 30,000 of the 70,000+ overseas affiliates operated by Japanese companies worldwide. Two-way China-Japan trade grew 13.6% year-on-year to 1.02 trillion yuan ($150.93 billion) between January and May, with China's imports from Japan surging 23.9%.
Strategic shift toward high-value activities
Tetsuro Homma, president of the Japanese Chamber of Commerce and Industry in China, stated: "China is no longer viewed simply as a vast consumer market by Japanese companies, but also as a vital manufacturing base and a hub of innovation. It is also a supply base for outstanding talent, and a training ground for Japanese-funded businesses to build and sharpen their competitiveness." Japanese firms are increasingly focusing on R&D, advanced manufacturing, digitalization, and green technologies in China, moving beyond traditional production roles.
Investment and trade data
China's actual use of foreign direct investment in high-tech industries surged 20.3% year-on-year to 116.33 billion yuan in the first four months, accounting for 40.4% of total FDI. This shift toward higher-value investment is relevant for medical aesthetics supply chains, where Japanese expertise in precision manufacturing, materials science, and device innovation is highly valued.
Sourcing context
Zhou Minliang, a professor at Northwestern Polytechnical University, noted that China's mature industrial ecosystem, efficient infrastructure, and vast domestic market provide advantages difficult to replicate elsewhere. For aesthetic buyers, this means Japanese suppliers in China can offer competitive pricing, rapid prototyping, and access to cutting-edge technologies in areas like smart lighting, electronics, and intelligent cockpit technologies—applicable to aesthetic device manufacturing.
What buyers should watch
Japanese automotive parts supplier Marelli Holdings is expanding in China in smart lighting and intelligent cockpit technologies, indicating broader cross-sector innovation that could spill over into medical aesthetics. The sustained commitment of Japanese firms to China suggests reliable supply chains for aesthetic devices, injectables, and OEM services, with potential for faster product iteration and cost efficiency. Buyers should monitor Japanese R&D centers in China for new aesthetic technologies and partnerships.
Source: Read the original report | Published: June 16, 2026